Workflow
浙江康恩贝制药股份有限公司 关于召开2024年度暨2025年第一季度业绩说明会的公告

Core Viewpoint - The company, Zhejiang Kang En Bei Pharmaceutical Co., Ltd., is set to hold a performance briefing on June 18, 2025, to discuss its 2024 annual report and Q1 2025 results, allowing investors to engage and ask questions [2][3][4]. Group 1: Meeting Details - The performance briefing will take place on June 18, 2025, from 13:30 to 14:30 [4]. - The location for the meeting is the Shanghai Stock Exchange Roadshow Center, with a virtual format combining video and online text interaction [4][5]. - Investors can submit questions from June 11 to June 17, 2025, through the Roadshow Center website or via the company's email [2][5]. Group 2: Participants - Key attendees from the company include Chairman Jiang Yi, Vice President and CFO Chen Ming, Secretary of the Board Jin Zucheng, and Independent Director Zeng Su [4]. Group 3: Investor Participation - Investors can participate online during the briefing and will receive timely responses to their questions [5]. - The company encourages pre-submission of questions through the designated channels before the event [5]. Group 4: Contact Information - Contact persons for inquiries are Chen Fang and Wang Jie, with provided phone numbers for further assistance [6].